{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T04:34:13Z","timestamp":1768797253890,"version":"3.49.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"ViiV Healthcare Europe"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.antiviral.2019.104552","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T01:58:34Z","timestamp":1562291914000},"page":"104552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected na\u00efve patients: results from a multicenter cohort study"],"prefix":"10.1016","volume":"169","author":[{"given":"Barbara","family":"Rossetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianmaria","family":"Baldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetana","family":"Sterrantino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Rusconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"De Vito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Giacometti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Gagliardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Colafigli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amedeo","family":"Capetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"d\u2019Ettorre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Celani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Lagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Ciccullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Di Giambenedetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giordano","family":"Madeddu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.104552_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1468-1293.2010.00857.x","article-title":"Late presentation of HIV infection: a consensus definition","volume":"12","author":"Antinori","year":"2011","journal-title":"HIV Med."},{"key":"10.1016\/j.antiviral.2019.104552_bib2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/QAD.0000000000001351","article-title":"Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir","volume":"31","author":"Bonfanti","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2019.104552_bib3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/QAI.0b013e318186eabc","article-title":"Late presenters in an HIV surveillance system in Italy during the period 1992-2006","volume":"49","author":"Borghi","year":"2008","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.antiviral.2019.104552_bib4","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0140-6736(13)61221-0","article-title":"Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, noninferiority SAILING study","volume":"382","author":"Cahn","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2019.104552_bib5","first-page":"2218","article-title":"Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily","volume":"17","author":"Celesia","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.antiviral.2019.104552_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00002030-200102160-00008","article-title":"Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis","volume":"15","author":"Detels","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.antiviral.2019.104552_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/QAI.0000000000000849","article-title":"Discontinuation of initial antiretroviral therapy in clinical practice: moving toward individualized therapy","volume":"71","author":"Di Biagio","year":"2016","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.antiviral.2019.104552_bib8","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/QAI.0000000000001397","article-title":"Initiation of antiretroviral therapy containing integrase inhibitors increases the risk of IRIS requiring hospitalization","volume":"76","author":"Dutertre","year":"2017","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2019.104552_bib9","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.qai.0000286597.57066.2b","article-title":"Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing","volume":"45","author":"Girardi","year":"2007","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.antiviral.2019.104552_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1615822","article-title":"Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa","volume":"377","author":"Hakim","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.104552_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/COH.0000000000000445","article-title":"Risks of cardiovascular or central nervous system adverse events and immune reconstitution inflammatory syndrome, for dolutegravir versus other antiretrovirals: meta-analysis of randomized trials","volume":"13","author":"Hill AM","year":"2018","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.antiviral.2019.104552_bib13","first-page":"47","article-title":"Late presentation for HIV care across Europe: update from the collaboration of observational HIV epidemiological research Europe (COHERE) study, 2010 to 2013","volume":"20","author":"Mocroft","year":"2015","journal-title":"Euro Surveill."},{"key":"10.1016\/j.antiviral.2019.104552_bib14","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(97)10291-4","article-title":"Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease","volume":"351","author":"Li","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.antiviral.2019.104552_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25227","article-title":"Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort","volume":"22","author":"Mondi","year":"2019","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.antiviral.2019.104552_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1473-3099(10)70026-8","article-title":"Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis","volume":"10","author":"M\u00fcller","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104552_bib18","first-page":"405","article-title":"Integrase strand transfer inhibitors and the emergence of immune reconstitution inflammatory syndrome (IRIS)","volume":"15","author":"Psichogiou","year":"2017","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.antiviral.2019.104552_bib19","series-title":"Integrase Inhibitors Are an Independent Risk Factor for IRIS: an ATHENA-Cohort Study,#731 Proceedings of the CROI 2017, Seattle, USA","author":"Wijting","year":"2017"},{"key":"10.1016\/j.antiviral.2019.104552_bib20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/hiv.12686","article-title":"Late diagnosis, delayed presentation and late presentation among persons enrolled in a clinical HIV cohort in Ontario, Canada (1999-2013)","volume":"20","author":"Wilton","year":"2019","journal-title":"HIV Med."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219301184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219301184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:30:14Z","timestamp":1759062614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219301184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":18,"alternative-id":["S0166354219301184"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104552","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected na\u00efve patients: results from a multicenter cohort study","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104552","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104552"}}